drugset / Trial / NCT00004731
Parkinson's Disease Treatment With Coenzyme Q10
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to compare the effects of varying dosage of coenzyme Q10 (CoQ10) versus a placebo in the treatment of Parkinson's disease (PD) in patients with early, untreated PD.
Timeline
- Start
- 1998-09
- Primary completion
- —
- Completion
- 2003-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Coenzyme Q10 | Other / unclassified | 300 mg | — |
| Subject | Coenzyme Q10 | Other / unclassified | 600 mg | — |
| Subject | Coenzyme Q10 | Other / unclassified | 1200 mg | — |